Thiabendazole for the prophylaxis of strongyloidiasis in immunosuppressed patients with hematological diseases: a randomized double-blind placebo-controlled study

Haematologica. 2002 Jun;87(6):663-4.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Double-Blind Method
  • Female
  • Hematologic Diseases / complications*
  • Hematologic Diseases / drug therapy
  • Humans
  • Immunocompromised Host
  • Male
  • Middle Aged
  • Strongyloidiasis / drug therapy
  • Strongyloidiasis / prevention & control*
  • Thiabendazole / therapeutic use*
  • Treatment Outcome

Substances

  • Thiabendazole